Reuters logo
BRIEF-Spectrum Pharmaceuticals reports Q3 non-GAAP loss per share of $0.11
November 2, 2017 / 8:21 PM / 15 days ago

BRIEF-Spectrum Pharmaceuticals reports Q3 non-GAAP loss per share of $0.11

Nov 2 (Reuters) - Spectrum Pharmaceuticals Inc

* Spectrum Pharmaceuticals reports third quarter 2017 financial results and pipeline update

* Q3 non-GAAP loss per share $0.11

* Q3 loss per share $0.22

* Q3 revenue $36.4 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below